> top > docs > PMC:3585731 > spans > 7333-8203 > annotations

PMC:3585731 / 7333-8203 JSONTXT

Annnotations TAB JSON ListView MergeView

testone

Id Subject Object Predicate Lexical cue
T28489 724-731 Positive_regulation denotes induced
T28488 747-751 Protein denotes TNFα
T28487 138-142 Protein denotes TNFα
T28486 53-58 Protein denotes IGF-1
T28485 44-48 Protein denotes bFGF
R19753 T28488 T28489 causeOf TNFα,induced

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T28685 862-869 VB denotes plotted
T28684 858-861 VB denotes was
T28683 847-857 NN denotes average±SD
T28682 845-846 -COMMA- denotes ,
T28681 839-845 NN denotes graphs
T28680 835-838 DT denotes all
T28679 832-834 IN denotes In
T28678 822-830 NN denotes PD166866
T28677 819-821 NN denotes µM
T28676 816-818 CD denotes 20
T28675 812-815 CC denotes and
T28674 803-811 NN denotes PD173074
T28673 800-802 NN denotes µM
T28672 798-799 CD denotes 2
T28671 795-797 IN denotes of
T28670 786-794 NN denotes presence
T28669 782-785 DT denotes the
T28668 779-781 IN denotes in
T28667 769-778 NN denotes condition
T28666 763-768 NN denotes serum
T28665 758-762 JJ denotes full
T28664 752-757 IN denotes under
T28663 747-751 NN denotes TNFα
T28662 744-746 CC denotes or
T28661 735-743 NN denotes zVAD.fmk
T28660 732-734 IN denotes by
T28659 724-731 VB denotes induced
T28658 720-723 VB denotes was
T28657 714-719 NN denotes death
T28656 709-713 NN denotes Cell
T28655 707-708 -RRB- denotes )
T28654 706-707 NN denotes D
T28653 705-706 -LRB- denotes (
T28652 698-704 NN denotes assay.
T28651 688-697 NN denotes viability
T28650 685-687 IN denotes by
T28649 676-684 VB denotes followed
T28648 672-675 NN denotes hrs
T28647 669-671 CD denotes 24
T28646 665-668 IN denotes for
T28645 660-664 DT denotes both
T28644 657-659 CC denotes or
T28643 655-656 -COMMA- denotes ,
T28642 647-655 NN denotes zVAD.fmk
T28641 645-646 -COMMA- denotes ,
T28640 642-645 NN denotes FGF
T28639 637-641 IN denotes with
T28638 629-636 VB denotes treated
T28637 624-628 VB denotes were
T28636 613-623 NN denotes conditions
T28635 608-612 JJ denotes free
T28634 602-607 NN denotes serum
T28633 596-601 IN denotes under
T28632 590-595 NN denotes Cells
T28631 588-589 -RRB- denotes )
T28630 587-588 NN denotes C
T28629 586-587 -LRB- denotes (
T28628 575-585 NN denotes viability.
T28627 570-574 NN denotes cell
T28626 567-569 IN denotes of
T28625 555-566 NN denotes measurement
T28624 552-554 IN denotes by
T28623 543-551 VB denotes followed
T28622 539-542 NN denotes hrs
T28621 536-538 CD denotes 24
T28620 532-535 IN denotes for
T28619 521-531 NN denotes conditions
T28618 516-520 JJ denotes free
T28617 510-515 NN denotes serum
T28616 504-509 IN denotes under
T28615 498-503 NN denotes Nec-1
T28614 494-497 CC denotes and
T28613 492-493 -COMMA- denotes ,
T28612 485-492 NN denotes factors
T28611 478-484 NN denotes growth
T28610 468-477 VB denotes indicated
T28609 464-467 DT denotes the
T28608 462-463 -COMMA- denotes ,
T28607 454-462 NN denotes zVAD.fmk
T28606 449-453 IN denotes with
T28605 441-448 VB denotes treated
T28604 436-440 VB denotes were
T28603 430-435 NN denotes Cells
T28602 428-429 -RRB- denotes )
T28601 427-428 NN denotes B
T28600 426-427 -LRB- denotes (
T28599 417-425 NN denotes figures.
T28598 413-416 DT denotes the
T28597 410-412 IN denotes in
T28596 400-409 VB denotes indicated
T28554 138-142 NN denotes TNFα
T28553 133-137 IN denotes with
T28552 125-132 VB denotes treated
T28551 120-124 VB denotes were
T28550 114-119 NN denotes cells
T28549 109-113 NN denotes L929
T28548 107-108 -RRB- denotes )
T28547 106-107 NN denotes A
T28546 105-106 -LRB- denotes (
T28545 95-103 NN denotes zVAD.fmk
T28544 90-94 IN denotes with
T28543 82-89 NN denotes concert
T28542 79-81 IN denotes in
T28541 67-78 NN denotes necroptosis
T28540 59-66 VB denotes promote
T28539 53-58 NN denotes IGF-1
T28538 49-52 CC denotes and
T28537 44-48 NN denotes bFGF
T28595 397-399 CC denotes or
T28594 389-396 NN denotes section
T28593 380-387 NNP denotes Methods
T28592 376-379 CC denotes and
T28591 366-375 NNP denotes Materials
T28590 361-364 DT denotes the
T28589 358-360 IN denotes in
T28588 351-357 VB denotes listed
T28587 347-350 VB denotes are
T28586 340-346 NN denotes agents
T28585 319-339 JJ denotes necroptosis-inducing
T28584 315-318 DT denotes all
T28583 312-314 IN denotes of
T28582 297-311 NN denotes concentrations
T28581 293-296 DT denotes The
T28580 286-291 NN denotes assay
T28579 276-285 NN denotes Viability
T28578 262-275 JJ denotes CellTiter-Glo
T28577 258-261 DT denotes the
T28576 252-257 VB denotes using
T28575 249-251 NN denotes hr
T28574 246-248 CD denotes 24
T28573 240-245 IN denotes after
T28572 229-239 VB denotes determined
T28571 225-228 VB denotes was
T28570 215-224 NN denotes viability
T28569 210-214 NN denotes Cell
T28568 198-208 NN denotes conditions
T28567 193-197 JJ denotes free
T28566 187-192 NN denotes serum
T28565 184-186 CC denotes or
T28564 182-183 -RRB- denotes )
T28563 179-182 NN denotes FBS
T28562 177-178 NN denotes %
T28561 175-177 CD denotes 10
T28560 174-175 -LRB- denotes (
T28559 168-173 NN denotes serum
T28558 161-167 JJ denotes normal
T28557 155-160 IN denotes under
T28556 146-154 NN denotes zVAD.fmk
T28555 143-145 CC denotes or
R19754 T28537 T28538 arg1Of bFGF,and
R19755 T28538 T28540 arg1Of and,promote
R19756 T28539 T28538 arg2Of IGF-1,and
R19757 T28540 T28542 arg1Of promote,in
R19758 T28541 T28540 arg2Of necroptosis,promote
R19759 T28542 T28544 arg1Of in,with
R19760 T28543 T28542 arg2Of concert,in
R19761 T28545 T28542 arg3Of zVAD.fmk,in
R19762 T28547 T28546 arg2Of A,(
R19763 T28548 T28546 arg3Of ),(
R19764 T28550 T28546 arg1Of cells,(
R19765 T28550 T28549 arg1Of cells,L929
R19766 T28550 T28551 arg1Of cells,were
R19767 T28550 T28552 arg2Of cells,treated
R19768 T28552 T28551 arg2Of treated,were
R19769 T28552 T28553 arg1Of treated,with
R19790 T28572 T28573 arg1Of determined,after
R19791 T28572 T28576 modOf determined,using
R19792 T28575 T28573 arg2Of hr,after
R19793 T28575 T28574 arg1Of hr,24
R19794 T28580 T28576 arg2Of assay,using
R19795 T28580 T28577 arg1Of assay,the
R19796 T28580 T28578 arg1Of assay,CellTiter-Glo
R19797 T28580 T28579 arg1Of assay,Viability
R19798 T28582 T28581 arg1Of concentrations,The
R19799 T28582 T28583 arg1Of concentrations,of
R19800 T28582 T28587 arg1Of concentrations,are
R19801 T28582 T28588 arg2Of concentrations,listed
R19802 T28586 T28583 arg2Of agents,of
R19803 T28586 T28584 arg1Of agents,all
R19804 T28586 T28585 arg1Of agents,necroptosis-inducing
R19805 T28588 T28587 arg2Of listed,are
R19806 T28588 T28589 arg1Of listed,in
R19807 T28588 T28606 arg1Of listed,with
R19809 T28589 T28590 arg1Of in,the
R19810 T28591 T28592 arg1Of Materials,and
R19811 T28592 T28589 arg2Of and,in
R19812 T28592 T28604 modOf and,were
R19813 T28593 T28592 arg2Of Methods,and
R19814 T28594 T28595 arg1Of section,or
R19815 T28594 T28596 arg2Of section,indicated
R19816 T28594 T28604 arg1Of section,were
R19817 T28594 T28605 arg2Of section,treated
R19818 T28596 T28597 arg1Of indicated,in
R19819 T28601 T28600 arg2Of B,(
R19820 T28602 T28600 arg3Of ),(
R19821 T28603 T28597 arg2Of Cells,in
R19822 T28603 T28598 arg1Of Cells,the
R19823 T28603 T28599 arg1Of Cells,figures.
R19824 T28603 T28600 arg1Of Cells,(
R19825 T28605 T28604 arg2Of treated,were
R19826 T28607 T28606 arg2Of zVAD.fmk,with
R19827 T28607 T28608 arg1Of zVAD.fmk,","
R19834 T28615 T28658 arg1Of Nec-1,was
R19835 T28615 T28659 arg2Of Nec-1,induced
R19859 T28638 T28646 arg1Of treated,for
R19865 T28645 T28644 arg2Of both,or
R19866 T28648 T28646 arg2Of hrs,for
R19867 T28648 T28647 arg1Of hrs,24
R19868 T28648 T28649 arg2Of hrs,followed
R19869 T28652 T28649 arg1Of assay.,followed
R19870 T28652 T28650 arg2Of assay.,by
R19871 T28652 T28651 arg1Of assay.,viability
R19872 T28652 T28653 arg1Of assay.,(
R19873 T28654 T28653 arg2Of D,(
R19874 T28655 T28653 arg3Of ),(
R19877 T28657 T28656 arg1Of death,Cell
R19879 T28659 T28658 arg2Of induced,was
R19880 T28659 T28664 arg1Of induced,under
R19881 T28659 T28668 arg1Of induced,in
R19882 T28661 T28662 arg1Of zVAD.fmk,or
R19883 T28662 T28659 arg1Of or,induced
R19884 T28662 T28660 arg2Of or,by
R19885 T28663 T28662 arg2Of TNFα,or
R19886 T28667 T28664 arg2Of condition,under
R19887 T28667 T28665 arg1Of condition,full
R19888 T28667 T28666 arg1Of condition,serum
R19889 T28668 T28669 arg1Of in,the
R19890 T28668 T28671 arg1Of in,of
R19891 T28670 T28668 arg2Of presence,in
R19892 T28672 T28673 arg1Of 2,µM
R19893 T28674 T28672 arg1Of PD173074,2
R19894 T28674 T28675 arg1Of PD173074,and
R19895 T28675 T28668 arg3Of and,in
R19896 T28678 T28675 arg2Of PD166866,and
R19897 T28678 T28676 arg1Of PD166866,20
R19898 T28678 T28677 arg1Of PD166866,µM
R19899 T28681 T28679 arg2Of graphs,In
R19900 T28681 T28680 arg1Of graphs,all
R19901 T28683 T28684 arg1Of average±SD,was
R19902 T28683 T28685 arg2Of average±SD,plotted
R19903 T28685 T28679 arg1Of plotted,In
R19904 T28685 T28682 arg1Of plotted,","
R19905 T28685 T28684 arg2Of plotted,was
R19770 T28554 T28555 arg1Of TNFα,or
R19771 T28555 T28553 arg2Of or,with
R19772 T28555 T28557 arg1Of or,under
R19773 T28556 T28555 arg2Of zVAD.fmk,or
R19774 T28559 T28558 arg1Of serum,normal
R19775 T28559 T28560 arg1Of serum,(
R19776 T28559 T28565 arg1Of serum,or
R19777 T28561 T28562 arg1Of 10,%
R19778 T28563 T28560 arg2Of FBS,(
R19779 T28563 T28561 arg1Of FBS,10
R19780 T28564 T28560 arg3Of ),(
R19781 T28565 T28557 arg2Of or,under
R19782 T28568 T28565 arg2Of conditions,or
R19783 T28568 T28566 arg1Of conditions,serum
R19784 T28568 T28567 arg1Of conditions,free
R19785 T28570 T28569 arg1Of viability,Cell
R19786 T28570 T28571 arg1Of viability,was
R19787 T28570 T28572 arg2Of viability,determined
R19788 T28570 T28576 arg1Of viability,using
R19789 T28572 T28571 arg2Of determined,was
R19808 T28588 T28614 arg1Of listed,and
R19828 T28612 T28608 arg2Of factors,","
R19829 T28612 T28609 arg1Of factors,the
R19830 T28612 T28610 arg2Of factors,indicated
R19831 T28612 T28611 arg1Of factors,growth
R19832 T28614 T28613 arg1Of and,","
R19833 T28615 T28616 arg1Of Nec-1,under
R19836 T28619 T28616 arg2Of conditions,under
R19837 T28619 T28617 arg1Of conditions,serum
R19838 T28619 T28618 arg1Of conditions,free
R19839 T28619 T28620 arg1Of conditions,for
R19840 T28622 T28620 arg2Of hrs,for
R19841 T28622 T28621 arg1Of hrs,24
R19842 T28622 T28623 arg2Of hrs,followed
R19843 T28625 T28623 arg1Of measurement,followed
R19844 T28625 T28624 arg2Of measurement,by
R19845 T28625 T28626 arg1Of measurement,of
R19846 T28625 T28633 arg1Of measurement,under
R19847 T28628 T28627 arg1Of viability.,cell
R19848 T28628 T28629 arg1Of viability.,(
R19849 T28630 T28629 arg2Of C,(
R19850 T28631 T28629 arg3Of ),(
R19851 T28632 T28626 arg2Of Cells,of
R19852 T28632 T28628 arg1Of Cells,viability.
R19853 T28634 T28637 modOf serum,were
R19854 T28636 T28635 arg1Of conditions,free
R19855 T28636 T28637 arg1Of conditions,were
R19856 T28636 T28638 arg2Of conditions,treated
R19857 T28638 T28637 arg2Of treated,were
R19858 T28638 T28639 arg1Of treated,with
R19860 T28640 T28641 arg1Of FGF,","
R19861 T28641 T28644 arg1Of ",",or
R19862 T28642 T28641 arg2Of zVAD.fmk,","
R19863 T28644 T28639 arg2Of or,with
R19864 T28644 T28643 arg1Of or,","
R19875 T28657 T28633 arg2Of death,under
R19876 T28657 T28634 arg1Of death,serum
R19878 T28659 T28614 arg2Of induced,and

bionlp-st-ge-2016-test-proteins

Id Subject Object Predicate Lexical cue
T28516 747-751 Protein denotes TNFα
T28515 138-142 Protein denotes TNFα
T28514 53-58 Protein denotes IGF-1
T28513 44-48 Protein denotes bFGF

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T28693 747-751 http://www.uniprot.org/uniprot/P01375 denotes TNFα
T28692 138-142 http://www.uniprot.org/uniprot/P01375 denotes TNFα
T28691 642-645 http://www.uniprot.org/uniprot/Q788Q8 denotes FGF
T28690 44-48 http://www.uniprot.org/uniprot/Q788Q8 denotes bFGF

UBERON-AE

Id Subject Object Predicate Lexical cue
T28503 763-768 http://purl.obolibrary.org/obo/UBERON_0001977 denotes serum
T28502 602-607 http://purl.obolibrary.org/obo/UBERON_0001977 denotes serum
T28501 510-515 http://purl.obolibrary.org/obo/UBERON_0001977 denotes serum
T28500 187-192 http://purl.obolibrary.org/obo/UBERON_0001977 denotes serum
T28499 168-173 http://purl.obolibrary.org/obo/UBERON_0001977 denotes serum

GO-BP

Id Subject Object Predicate Lexical cue
T28525 714-719 http://purl.obolibrary.org/obo/GO_0016265 denotes death
T28524 709-731 http://purl.obolibrary.org/obo/GO_0071888 denotes Cell death was induced
T28523 709-731 http://purl.obolibrary.org/obo/GO_0043276 denotes Cell death was induced
T28522 709-719 http://purl.obolibrary.org/obo/GO_0008219 denotes Cell death
T28521 478-484 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T28520 319-330 http://purl.obolibrary.org/obo/GO_0097528 denotes necroptosis
T28519 67-78 http://purl.obolibrary.org/obo/GO_0097528 denotes necroptosis
T28518 319-330 http://purl.obolibrary.org/obo/GO_0070266 denotes necroptosis
T28517 67-78 http://purl.obolibrary.org/obo/GO_0070266 denotes necroptosis

GO-CC

Id Subject Object Predicate Lexical cue
T28528 709-713 http://purl.obolibrary.org/obo/GO_0005623 denotes Cell
T28527 210-214 http://purl.obolibrary.org/obo/GO_0005623 denotes Cell
T28526 114-119 http://purl.obolibrary.org/obo/GO_0005623 denotes cells

sentences

Id Subject Object Predicate Lexical cue
T28508 832-870 Sentence denotes In all graphs, average±SD was plotted.
T28507 293-831 Sentence denotes The concentrations of all necroptosis-inducing agents are listed in the Materials and Methods section or indicated in the figures. (B) Cells were treated with zVAD.fmk, the indicated growth factors, and Nec-1 under serum free conditions for 24 hrs followed by measurement of cell viability. (C) Cells under serum free conditions were treated with FGF, zVAD.fmk, or both for 24 hrs followed by viability assay. (D) Cell death was induced by zVAD.fmk or TNFα under full serum condition in the presence of 2 µM PD173074 and 20 µM PD166866.
T28506 210-292 Sentence denotes Cell viability was determined after 24 hr using the CellTiter-Glo Viability assay.
T28505 105-209 Sentence denotes (A) L929 cells were treated with TNFα or zVAD.fmk under normal serum (10% FBS) or serum free conditions.
T28504 44-104 Sentence denotes bFGF and IGF-1 promote necroptosis in concert with zVAD.fmk.
T47 0-104 Sentence denotes 10.1371/journal.pone.0056576.g001 Figure 1 bFGF and IGF-1 promote necroptosis in concert with zVAD.fmk.
T48 105-209 Sentence denotes (A) L929 cells were treated with TNFα or zVAD.fmk under normal serum (10% FBS) or serum free conditions.
T49 210-292 Sentence denotes Cell viability was determined after 24 hr using the CellTiter-Glo Viability assay.
T50 293-831 Sentence denotes The concentrations of all necroptosis-inducing agents are listed in the Materials and Methods section or indicated in the figures. (B) Cells were treated with zVAD.fmk, the indicated growth factors, and Nec-1 under serum free conditions for 24 hrs followed by measurement of cell viability. (C) Cells under serum free conditions were treated with FGF, zVAD.fmk, or both for 24 hrs followed by viability assay. (D) Cell death was induced by zVAD.fmk or TNFα under full serum condition in the presence of 2 µM PD173074 and 20 µM PD166866.
T51 832-870 Sentence denotes In all graphs, average±SD was plotted.

simple1

Id Subject Object Predicate Lexical cue
T28536 747-751 Protein denotes TNFα
T28535 138-142 Protein denotes TNFα
T28534 53-58 Protein denotes IGF-1
T28533 44-48 Protein denotes bFGF

BioNLP16_DUT

Id Subject Object Predicate Lexical cue
T28689 747-751 Protein denotes TNFα
T28688 138-142 Protein denotes TNFα
T28687 53-58 Protein denotes IGF-1
T28686 44-48 Protein denotes bFGF

BioNLP16_Messiy

Id Subject Object Predicate Lexical cue
T28705 747-751 Protein denotes TNFα
T28704 138-142 Protein denotes TNFα
T28703 53-58 Protein denotes IGF-1
T28702 44-48 Protein denotes bFGF

DLUT931

Id Subject Object Predicate Lexical cue
T28697 747-751 Protein denotes TNFα
T28696 138-142 Protein denotes TNFα
T28695 53-58 Protein denotes IGF-1
T28694 44-48 Protein denotes bFGF

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue
T28906 430-435 Entity denotes Cells
T28905 138-142 Protein denotes TNFα
T28904 647-655 Entity denotes zVAD.fmk
T28903 498-503 Protein denotes Nec-1
T28902 258-291 Protein denotes the CellTiter-Glo Viability assay
T28901 800-811 Entity denotes µM PD173074
T28900 454-463 Entity denotes zVAD.fmk,
T28899 669-675 Protein denotes 24 hrs
T28898 146-154 Entity denotes zVAD.fmk
T28897 735-743 Entity denotes zVAD.fmk
T28896 175-182 Protein denotes 10% FBS
T28895 747-751 Protein denotes TNFα
T28894 567-584 Entity denotes of cell viability
T28893 44-48 Protein denotes bFGF
T28892 536-584 Protein denotes 24 hrs followed by measurement of cell viability
T28891 262-266 Entity denotes Cell
T28890 53-58 Protein denotes IGF-1
T28889 642-645 Entity denotes FGF
T28888 95-103 Entity denotes zVAD.fmk
T28887 590-623 Entity denotes Cells under serum free conditions

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T28875 869-870 . denotes .
T28874 862-869 VBN denotes plotted
T28873 858-861 VBD denotes was
T28872 855-857 NNP denotes SD
T28871 854-855 NN denotes ±
T28870 847-854 JJ denotes average
T28869 845-846 , denotes ,
T28868 839-845 NNS denotes graphs
T28867 835-838 DT denotes all
T28866 832-834 IN denotes In
T28865 830-831 . denotes .
T28864 822-830 NNP denotes PD166866
T28863 819-821 NNP denotes µM
T28862 816-818 CD denotes 20
T28861 812-815 CC denotes and
T28860 803-811 NNP denotes PD173074
T28859 800-802 NNP denotes µM
T28858 798-799 CD denotes 2
T28857 795-797 IN denotes of
T28856 786-794 NN denotes presence
T28855 782-785 DT denotes the
T28854 779-781 IN denotes in
T28853 769-778 NN denotes condition
T28852 763-768 NN denotes serum
T28851 758-762 JJ denotes full
T28850 752-757 IN denotes under
T28849 747-751 NNP denotes TNFα
T28848 744-746 CC denotes or
T28847 735-743 NNP denotes zVAD.fmk
T28846 732-734 IN denotes by
T28845 724-731 VBN denotes induced
T28844 720-723 VBD denotes was
T28843 714-719 NN denotes death
T28842 709-713 NNP denotes Cell
T28841 707-708 -RRB- denotes )
T28840 706-707 NNP denotes D
T28839 705-706 -LRB- denotes (
T28838 703-704 . denotes .
T28837 698-703 NN denotes assay
T28836 688-697 NN denotes viability
T28835 685-687 IN denotes by
T28834 676-684 VBN denotes followed
T28833 672-675 NNS denotes hrs
T28832 669-671 CD denotes 24
T28831 665-668 IN denotes for
T28830 660-664 DT denotes both
T28829 657-659 CC denotes or
T28828 655-656 , denotes ,
T28827 647-655 NNP denotes zVAD.fmk
T28826 645-646 , denotes ,
T28825 642-645 NNP denotes FGF
T28824 637-641 IN denotes with
T28823 629-636 VBN denotes treated
T28822 624-628 VBD denotes were
T28821 613-623 NNS denotes conditions
T28820 608-612 JJ denotes free
T28819 602-607 NN denotes serum
T28818 596-601 IN denotes under
T28817 590-595 NNS denotes Cells
T28816 588-589 -RRB- denotes )
T28815 587-588 $ denotes C
T28814 586-587 -LRB- denotes (
T28811 570-574 NN denotes cell
T28810 567-569 IN denotes of
T28809 555-566 NN denotes measurement
T28808 552-554 IN denotes by
T28807 543-551 VBN denotes followed
T28806 539-542 NNS denotes hrs
T28805 536-538 CD denotes 24
T28804 532-535 IN denotes for
T28803 521-531 NNS denotes conditions
T28802 516-520 JJ denotes free
T28801 510-515 NN denotes serum
T28800 504-509 IN denotes under
T28799 498-503 NN denotes Nec-1
T28798 494-497 CC denotes and
T28797 492-493 , denotes ,
T28796 485-492 NNS denotes factors
T28795 478-484 NN denotes growth
T28794 468-477 JJ denotes indicated
T28793 464-467 DT denotes the
T28792 462-463 , denotes ,
T28791 454-462 NNP denotes zVAD.fmk
T28790 449-453 IN denotes with
T28789 441-448 VBN denotes treated
T28788 436-440 VBD denotes were
T28787 430-435 NNPS denotes Cells
T28786 428-429 -RRB- denotes )
T28785 427-428 NNP denotes B
T28784 426-427 -LRB- denotes (
T28783 424-425 . denotes .
T28782 417-424 NNS denotes figures
T28781 413-416 DT denotes the
T28780 410-412 IN denotes in
T28779 400-409 VBN denotes indicated
T28778 397-399 CC denotes or
T28777 389-396 NN denotes section
T28776 380-387 NNPS denotes Methods
T28775 376-379 CC denotes and
T28774 366-375 NNPS denotes Materials
T28773 361-364 DT denotes the
T28772 358-360 IN denotes in
T28771 351-357 VBN denotes listed
T28770 347-350 VBP denotes are
T28769 340-346 NNS denotes agents
T28768 319-339 JJ denotes necroptosis-inducing
T28767 315-318 DT denotes all
T28766 312-314 IN denotes of
T28765 297-311 NNS denotes concentrations
T28764 293-296 DT denotes The
T28763 291-292 . denotes .
T28762 286-291 NN denotes assay
T28761 276-285 NN denotes Viability
T28760 262-275 NNP denotes CellTiter-Glo
T28759 258-261 DT denotes the
T28758 252-257 VBG denotes using
T28757 249-251 NN denotes hr
T28756 246-248 CD denotes 24
T28755 240-245 IN denotes after
T28754 229-239 VBN denotes determined
T28753 225-228 VBD denotes was
T28752 215-224 NN denotes viability
T28751 210-214 NNP denotes Cell
T28750 208-209 . denotes .
T28749 198-208 NNS denotes conditions
T28748 193-197 JJ denotes free
T28747 187-192 NN denotes serum
T28746 184-186 CC denotes or
T28745 182-183 -RRB- denotes )
T28744 179-182 NNP denotes FBS
T28743 177-178 NN denotes %
T28742 175-177 CD denotes 10
T28741 174-175 -LRB- denotes (
T28740 168-173 NN denotes serum
T28739 161-167 JJ denotes normal
T28738 155-160 IN denotes under
T28737 146-154 NNP denotes zVAD.fmk
T28736 143-145 CC denotes or
T28735 138-142 NNP denotes TNFα
T28734 133-137 IN denotes with
T28733 125-132 VBN denotes treated
T28732 120-124 VBD denotes were
T28731 114-119 NNS denotes cells
T28730 109-113 NNP denotes L929
T28729 107-108 -RRB- denotes )
T28728 106-107 NNP denotes A
T28727 105-106 -LRB- denotes (
T28726 103-104 . denotes .
T28725 95-103 NNP denotes zVAD.fmk
T28724 90-94 IN denotes with
T28723 82-89 NN denotes concert
T28722 79-81 IN denotes in
T28721 67-78 NN denotes necroptosis
T28720 59-66 VB denotes promote
T28719 53-58 NNP denotes IGF-1
T28718 49-52 CC denotes and
T28717 44-48 NNP denotes bFGF
T28813 584-585 . denotes .
T28812 575-584 NN denotes viability
R19906 T28717 T28720 nsubj bFGF,promote
R19907 T28718 T28717 cc and,bFGF
R19908 T28719 T28717 conj IGF-1,bFGF
R19909 T28720 T28720 ROOT promote,promote
R19910 T28721 T28720 dobj necroptosis,promote
R19911 T28722 T28720 prep in,promote
R19912 T28723 T28722 pobj concert,in
R19913 T28724 T28723 prep with,concert
R19914 T28725 T28724 pobj zVAD.fmk,with
R19915 T28726 T28720 punct .,promote
R19916 T28727 T28733 punct (,treated
R19917 T28728 T28731 nmod A,cells
R19918 T28729 T28728 punct ),A
R19919 T28730 T28731 compound L929,cells
R19920 T28731 T28733 nsubjpass cells,treated
R19921 T28732 T28733 auxpass were,treated
R19922 T28733 T28733 ROOT treated,treated
R19923 T28734 T28733 prep with,treated
R19924 T28735 T28734 pobj TNFα,with
R19925 T28736 T28735 cc or,TNFα
R19926 T28737 T28735 conj zVAD.fmk,TNFα
R19927 T28738 T28733 prep under,treated
R19928 T28739 T28740 amod normal,serum
R19929 T28740 T28738 pobj serum,under
R19930 T28741 T28744 punct (,FBS
R19931 T28742 T28743 nummod 10,%
R19932 T28743 T28744 compound %,FBS
R19933 T28744 T28733 npadvmod FBS,treated
R19934 T28745 T28744 punct ),FBS
R19935 T28746 T28733 cc or,treated
R19936 T28747 T28749 nmod serum,conditions
R19937 T28748 T28749 amod free,conditions
R19938 T28749 T28733 conj conditions,treated
R19939 T28750 T28733 punct .,treated
R19940 T28751 T28752 compound Cell,viability
R19941 T28752 T28754 nsubjpass viability,determined
R19942 T28753 T28754 auxpass was,determined
R19943 T28754 T28754 ROOT determined,determined
R19944 T28755 T28754 prep after,determined
R19945 T28756 T28757 nummod 24,hr
R19946 T28757 T28755 pobj hr,after
R19947 T28758 T28754 advcl using,determined
R19948 T28759 T28762 det the,assay
R19949 T28760 T28762 compound CellTiter-Glo,assay
R19950 T28761 T28762 compound Viability,assay
R19951 T28762 T28758 dobj assay,using
R19952 T28763 T28754 punct .,determined
R19953 T28764 T28765 det The,concentrations
R19954 T28765 T28771 nsubjpass concentrations,listed
R19955 T28766 T28765 prep of,concentrations
R19956 T28767 T28769 det all,agents
R19957 T28768 T28769 amod necroptosis-inducing,agents
R19958 T28769 T28766 pobj agents,of
R19959 T28770 T28771 auxpass are,listed
R19960 T28771 T28771 ROOT listed,listed
R19961 T28772 T28771 prep in,listed
R19962 T28773 T28774 det the,Materials
R19963 T28774 T28772 pobj Materials,in
R19964 T28775 T28774 cc and,Materials
R19965 T28776 T28777 compound Methods,section
R19966 T28777 T28779 nsubj section,indicated
R19967 T28778 T28777 cc or,section
R19968 T28779 T28771 conj indicated,listed
R19969 T28780 T28779 prep in,indicated
R19970 T28781 T28782 det the,figures
R19971 T28782 T28780 pobj figures,in
R19972 T28783 T28779 punct .,indicated
R19973 T28784 T28785 punct (,B
R19974 T28785 T28785 ROOT B,B
R19975 T28786 T28785 punct ),B
R19976 T28787 T28789 nsubjpass Cells,treated
R19977 T28788 T28789 auxpass were,treated
R19978 T28789 T28789 ROOT treated,treated
R19979 T28790 T28789 prep with,treated
R19980 T28791 T28790 pobj zVAD.fmk,with
R19981 T28792 T28791 punct ",",zVAD.fmk
R19982 T28793 T28796 det the,factors
R19983 T28794 T28796 amod indicated,factors
R19984 T28795 T28796 compound growth,factors
R19985 T28796 T28790 pobj factors,with
R19986 T28797 T28789 punct ",",treated
R19987 T28798 T28789 cc and,treated
R19988 T28799 T28789 conj Nec-1,treated
R19989 T28800 T28799 prep under,Nec-1
R19990 T28801 T28802 npadvmod serum,free
R19991 T28802 T28803 amod free,conditions
R19992 T28803 T28800 pobj conditions,under
R19993 T28804 T28799 prep for,Nec-1
R19994 T28805 T28806 nummod 24,hrs
R19995 T28806 T28804 pobj hrs,for
R19996 T28807 T28806 acl followed,hrs
R19997 T28808 T28807 agent by,followed
R19998 T28809 T28808 pobj measurement,by
R19999 T28810 T28809 prep of,measurement
R20000 T28811 T28812 compound cell,viability
R20001 T28812 T28810 pobj viability,of
R20002 T28813 T28789 punct .,treated
R20003 T28814 T28815 punct (,C
R20004 T28815 T28815 ROOT C,C
R20005 T28816 T28815 punct ),C
R20006 T28817 T28823 nsubjpass Cells,treated
R20007 T28818 T28817 prep under,Cells
R20008 T28819 T28818 pobj serum,under
R20009 T28820 T28821 amod free,conditions
R20010 T28821 T28823 nsubjpass conditions,treated
R20011 T28822 T28823 auxpass were,treated
R20012 T28823 T28823 ROOT treated,treated
R20013 T28824 T28823 prep with,treated
R20014 T28825 T28824 pobj FGF,with
R20015 T28826 T28825 punct ",",FGF
R20016 T28827 T28825 conj zVAD.fmk,FGF
R20017 T28828 T28827 punct ",",zVAD.fmk
R20018 T28829 T28823 cc or,treated
R20019 T28830 T28831 advmod both,for
R20020 T28831 T28823 prep for,treated
R20021 T28832 T28833 nummod 24,hrs
R20022 T28833 T28831 pobj hrs,for
R20023 T28834 T28833 acl followed,hrs
R20024 T28835 T28834 agent by,followed
R20025 T28836 T28837 compound viability,assay
R20026 T28837 T28835 pobj assay,by
R20027 T28838 T28823 punct .,treated
R20028 T28839 T28845 punct (,induced
R20029 T28840 T28843 nmod D,death
R20030 T28841 T28840 punct ),D
R20031 T28842 T28843 compound Cell,death
R20032 T28843 T28845 nsubjpass death,induced
R20033 T28844 T28845 auxpass was,induced
R20034 T28845 T28845 ROOT induced,induced
R20035 T28846 T28845 agent by,induced
R20036 T28847 T28846 pobj zVAD.fmk,by
R20037 T28848 T28847 cc or,zVAD.fmk
R20038 T28849 T28847 conj TNFα,zVAD.fmk
R20039 T28850 T28845 prep under,induced
R20040 T28851 T28853 amod full,condition
R20041 T28852 T28853 compound serum,condition
R20042 T28853 T28850 pobj condition,under
R20043 T28854 T28845 prep in,induced
R20044 T28855 T28856 det the,presence
R20045 T28856 T28854 pobj presence,in
R20046 T28857 T28856 prep of,presence
R20047 T28858 T28860 nummod 2,PD173074
R20048 T28859 T28860 compound µM,PD173074
R20049 T28860 T28857 pobj PD173074,of
R20050 T28861 T28860 cc and,PD173074
R20051 T28862 T28864 nummod 20,PD166866
R20052 T28863 T28864 compound µM,PD166866
R20053 T28864 T28860 conj PD166866,PD173074
R20054 T28865 T28845 punct .,induced
R20055 T28866 T28874 prep In,plotted
R20056 T28867 T28868 det all,graphs
R20057 T28868 T28866 pobj graphs,In
R20058 T28869 T28874 punct ",",plotted
R20059 T28870 T28871 amod average,±
R20060 T28871 T28872 compound ±,SD
R20061 T28872 T28874 nsubjpass SD,plotted
R20062 T28873 T28874 auxpass was,plotted
R20063 T28874 T28874 ROOT plotted,plotted
R20064 T28875 T28874 punct .,plotted

bionlp-st-ge-2016-test-tees

Id Subject Object Predicate Lexical cue
T28716 819-830 Protein denotes µM PD166866
T28715 800-811 Protein denotes µM PD173074
T28714 735-751 Protein denotes zVAD.fmk or TNFα
T28713 647-655 Protein denotes zVAD.fmk
T28712 642-645 Protein denotes FGF
T28711 498-503 Protein denotes Nec-1
T28710 146-154 Protein denotes zVAD.fmk
T28709 138-142 Protein denotes TNFα
T28708 95-103 Protein denotes zVAD.fmk
T28707 53-58 Protein denotes IGF-1
T28706 44-48 Protein denotes bFGF

test3

Id Subject Object Predicate Lexical cue
T28498 747-751 Protein denotes TNFα
T28497 724-731 Positive_regulation denotes induced
T28496 138-142 Protein denotes TNFα
T28495 53-58 Protein denotes IGF-1
T28494 44-48 Protein denotes bFGF
T28493 747-751 Protein denotes TNFα
T28492 138-142 Protein denotes TNFα
T28491 53-58 Protein denotes IGF-1
T28490 44-48 Protein denotes bFGF